We are live on ! Find out more
GMDA

Gamida Cell Ltd. Ordinary Shares

Delisted

GMDA was delisted on the 5th of April, 2024.

63 hedge funds and large institutions have $45.8M invested in Gamida Cell Ltd. Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 15

11% less call options, than puts

Call options by funds: $382K | Put options by funds: $430K

14% less funds holding

Funds holding: 7363 (-10)

46% less capital invested

Capital invested by funds: $84.6M → $45.8M (-$38.8M)

50% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 18

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
63
Holders Change
-10
Holders Change %
-13.7%
% of All Funds
0.97%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
9
Increased
17
Reduced
15
Closed
18
Calls
$382K
Puts
$430K
Net Calls
-$48K
Net Calls Change
+$42K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$11.7M -$2.54M -771,423 -14%
Federated Hermes
2
Federated Hermes
Pennsylvania
$11.1M -$1.06M -323,250 -7%
RSCM
3
Rock Springs Capital Management
Maryland
$5.47M +$22.7K +6,900 +0.3%
HCM
4
Highbridge Capital Management
New York
$2.03M +$2.63M +797,544 New
AIM
5
ARK Investment Management
Florida
$1.91M +$420K +127,395 +20%
JP Morgan Chase
6
JP Morgan Chase
New York
$1.65M +$165K +50,224 +8%
BBA
7
Baker Bros. Advisors
New York
$1.55M
Mariner
8
Mariner
Kansas
$1.46M +$360K +109,300 +24%
LNWTC
9
Laird Norton Wetherby Trust Company
Washington
$1.34M
MIH
10
Meitav Investment House
Israel
$1.09M
BlackRock
11
BlackRock
New York
$924K +$7.01K +2,128 +0.6%
Renaissance Technologies
12
Renaissance Technologies
New York
$749K -$779K -236,384 -45%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$644K -$598K -181,593 -42%
YAVAPFMC
14
Yahav Achim Ve Achayot - Provident Funds Management Company
Israel
$443K
SFI
15
Susquehanna Fundamental Investments
Pennsylvania
$342K -$25.8K -7,833 -6%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$316K +$282K +85,758 +222%
Marshall Wace
17
Marshall Wace
United Kingdom
$272K -$877K -266,246 -71%
IBT
18
International Biotechnology Trust
United Kingdom
$271K
Victory Capital Management
19
Victory Capital Management
Texas
$255K -$53.8K -16,331 -14%
Morgan Stanley
20
Morgan Stanley
New York
$192K +$33.7K +10,238 +16%
FMBTD
21
First Midwest Bank Trust Division
Illinois
$186K -$218K -66,223 -48%
State Street
22
State Street
Massachusetts
$181K +$4.33K +1,314 +2%
LCS
23
Levin Capital Strategies
New York
$178K +$231K +70,000 New
Citadel Advisors
24
Citadel Advisors
Florida
$150K +$42.9K +13,010 +28%
PTP
25
Platform Technology Partners
New York
$140K -$2.47K -750 -1%

GMDA Hedge Fund Activity: Q4 2021 in Review

63 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q4 2021, worth a combined $45.8M — down 46% from $84.6M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of GMDA and 9 opened new positions — a net loss of 9 holders — while 15 trimmed existing stakes and 17 added.

The largest buyer was Highbridge Capital Management, opening a new position worth an estimated $2.63M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $6.76M sold.

  • 63 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q4 2021, down from 73 in Q3 2021.
  • Funds reported $45.8M of Gamida Cell Ltd. Ordinary Shares stock for Q4 2021, down 46% quarter-over-quarter.
  • 9 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q4 2021 and 18 closed out, a net change of -9 holders.
  • The largest Gamida Cell Ltd. Ordinary Shares buyer in Q4 2021 was Highbridge Capital Management, an estimated $2.63M added.
  • The largest Gamida Cell Ltd. Ordinary Shares seller in Q4 2021 was Stonepine Capital Management, an estimated $6.76M sold.

Based on aggregated 13F filings for Q4 2021.